Skip to content

Jazz Pharmaceuticals JAZZ Deferred Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate

Deferred Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate at other companies

Jones Lang LaSalle logo
Jones Lang LaSalleJLL
-$2.48M
SBA Communications logo
SBA CommunicationsSBAC
$26.11M+898%
Two Harbors Investment Corporation logo
Two Harbors Investment CorporationTWO
Flutter Entertainment logo
Flutter EntertainmentFLUT
Two Harbors Investment Corporation logo
Two Harbors Investment CorporationTWO
Popular logo
PopularBPOP

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept jazz:DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate.

The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate?
Jazz Pharmaceuticals (JAZZ) reported deferred income tax expense (benefit), increase (decrease) in tax rate of -$518.75K in Q4 2025.
How has Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate changed year-over-year?
Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate decreased by 321.2% year-over-year, from $234.5K to -$518.75K.
What is the long-term trend for Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate?
Over 4 years (2021 to 2025), Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate has grown at a -70.1% compound annual growth rate (CAGR), from $261.26M to -$2.08M.
What does deferred income tax expense (benefit), increase (decrease) in tax rate mean?
The tax impact caused specifically by changes in statutory tax rates.
How do you interpret deferred income tax expense (benefit), increase (decrease) in tax rate?
A significant expense or benefit indicates a major legislative change affecting the company's future tax burden.
How does deferred income tax expense (benefit), increase (decrease) in tax rate compare across companies?
Highly dependent on the political and legislative environment of the jurisdictions where the company operates.